Leap Therapeutics Inc.

NASDAQ: LPTX · Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM

Leap Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
47.25M 70.64M 65.5M 114.92M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
823K 966K 1.71M 383K
Receivables
704K 771K 2.1M 1.19M
Inventory
n/a n/a n/a n/a
Other Current Assets
86K 183K 351K n/a
Total Current Assets
48.04M 71.6M 67.95M 116.87M
Property-Plant & Equipment
262K 262K 689K 495K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.08M 1.23M 2.4M 1.04M
Total Assets
49.12M 72.83M 70.35M 117.91M
Account Payables
4.74M 6.46M 5.66M 4.19M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
266K n/a 416K 432K
Other Current Liabilities
8.8M 2.78M 2.21M 2.25M
Total Current Liabilities
14.08M 12.68M 11.22M 9.99M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 262K 37K
Total Liabilities
14.08M 12.68M 11.49M 10.02M
Total Debt
266K 262K 678K 469K
Common Stock
38K 26K 99K 88K
Retained Earnings
-467.37M -399.58M -318.17M -263.57M
Comprehensive Income
-120K 106K 128K -267K
Shareholders Equity
35.05M 60.14M 58.87M 107.89M
Total Investments
n/a n/a n/a n/a